USA flag logo/image

An Official Website of the United States Government

THE OBJECTIVE OF THIS GRANT IS TO IDENTIFY THE ACTIVE PRINCIPLE RESPONSIBLE FOR…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
3249
Program Year/Program:
1985 / SBIR
Agency Tracking Number:
3249
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Mora & Dahlberg Pharmaceutical
1330 Coral Way, Suite 409 Miami, FL 33145
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1985
Title: THE OBJECTIVE OF THIS GRANT IS TO IDENTIFY THE ACTIVE PRINCIPLE RESPONSIBLE FOR AN ANTIASTHMATIC ACTIVITY DISCOVERED IN THE RESIN OF THE RED CEDAR TREE.
Agency: HHS
Contract: N/A
Award Amount: $41,080.00
 

Abstract:

THE OBJECTIVE OF THIS GRANT IS TO IDENTIFY THE ACTIVE PRINCIPLE RESPONSIBLE FOR AN ANTIASTHMATIC ACTIVITY DISCOVERED IN THE RESIN OF THE RED CEDAR TREE. CEDAR HAD BEEN USED AS AN ANTIASTHMATIC FOLK REMEDY IN RURAL CUBA FOR MANY GENERATIONS BEFORE DR. RENE M. MORA, A CUBAN PHYSICIAN, BEGAN USING THE RESIN PREPARATION WITH REMARKABLE SUCCESS. THE ANECDOTAL DATA OFFERED IN THIS REPORT ARE NOW CORROBORATED BY RESULTS OF PRELIMINARY EXPERIMENTS IN TWO ANIMAL MODELS. IN ASCARIS-SENSITIVE SHEEP, THE INCREASE IN SPECIFIC LUNG RESISTANCE THAT ONE NORMALLY OBSERVES IN RESPONSE TO AN AEROSOL OF A. SUUM IS REDUCED SIGNIFICANTLY BY ONE 5-WEEK TREATMENT WITH ASTHMACEDAR. IN OVALBUMIN-SENSITIZED GUINEA PIGS, THE CONTRACTIVE RESPONSE RESULTING FROM ANTIGEN EXPOSURE IS MITIGATED BOTH BY THE FEEDING OF CEDAR RESIN TO THE GUINEA PIGS FOR SEVERAL WEEKS AND BY DIRECT INCUBATION OF THE STRIPS WITH THE PREPARATION. IN THE GUINEA PIG SYSTEM, THE CEDAR RESIN APPEARS NOT BE AN ANTIHISTAMINE OR ANTILEUKOTRIENE, BUT RATHER TO BE ACTING THROUGH ANOTHER MECHANISM. NONE OF THE HUMAN OR ANIMAL SUBJECTS TO WHOM THIS DRUG HAS BEEN ADMINISTERED HAS REVEALED ANY SIGNS OF TOXICITY. THE RELATIVE SPEED AND ECONOMY OF THE IN VITRO GUINEA PIG BIOASSAY MAKES FEASIBLE THE PROPOSAL TO FRACTIONATE AND IDENTIFY THE ACTIVE COMPONENT IN THE CEDAR RESIN.

Principal Investigator:

Albert e. dahlberg
PRINCIPAL INVESTIGATOR
3053732300

Business Contact:

Small Business Information at Submission:

Mora & Dahlberg Pharmaceutical
1330 Coral Way, Suite 409 Miami, FL 33145

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No